BR9810742A - Derivados de 5-naftalen -1il-1,3-dioxana, preparação dos mesmos e aplicação em terapia - Google Patents

Derivados de 5-naftalen -1il-1,3-dioxana, preparação dos mesmos e aplicação em terapia

Info

Publication number
BR9810742A
BR9810742A BR9810742-9A BR9810742A BR9810742A BR 9810742 A BR9810742 A BR 9810742A BR 9810742 A BR9810742 A BR 9810742A BR 9810742 A BR9810742 A BR 9810742A
Authority
BR
Brazil
Prior art keywords
group
therapy
application
nitrogen
preparation
Prior art date
Application number
BR9810742-9A
Other languages
English (en)
Inventor
Gihad Dargazanli
Patrick Lardenois
Jonathan Frost
Pascal George
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9706944A external-priority patent/FR2764287B1/fr
Priority claimed from FR9706947A external-priority patent/FR2764291B1/fr
Priority claimed from FR9706945A external-priority patent/FR2764288B1/fr
Priority claimed from FR9706946A external-priority patent/FR2764289B1/fr
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of BR9810742A publication Critical patent/BR9810742A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Patente de Invenção: <B>"DERIVADOS DE 5-NAFTALEN-1-IL-1,3-DIOXANA, PREPARAçãO DOS MESMOS E APLICAçãO EM TERAPIA"<D>. Compostos de fórmula geral (I) na qual R~ 1~ representa um grupo alquila, V representa um átomo de hidrogênio ou um grupo alquila linear ou ramificado, cicloalquila, cicloalquilmetila, fenilalquila eventualmente substituído sobre o núcleo fenila, carboximetila, alcoxicarbonilmetila, carbamoilmetila eventualmente substituído sobre o nitrogênio, W representa um grupo carboximetila, alcoxicarbonilmetila, carbamoilmetila eventualmente substituído sobre o nitrogênio, um grupo cíclico que tem de 4 a 7 ângulos e que contém eventualmente um átomo de oxigênio ou de enxofre ou um grupo piridinilmetila, 1-metilpirrolilmetila, furanilmetila, tienilmetila ou 1,3-tiazolilmetila ou então V e W formam juntos e com o átomo de nitrogênio, um grupo pirrolidinila, piperidinila ou 1,2,3,4-tetrahidroisoquinoleína. Aplicação em terapia.
BR9810742-9A 1997-06-05 1998-06-03 Derivados de 5-naftalen -1il-1,3-dioxana, preparação dos mesmos e aplicação em terapia BR9810742A (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR9706944A FR2764287B1 (fr) 1997-06-05 1997-06-05 Derives de 5-naphtalen-1-yl-1,3-dioxanes, leur preparation et leur application en therapeutique
FR9706947A FR2764291B1 (fr) 1997-06-05 1997-06-05 Derives de 5-naphtalen-1-yl-1,3-dioxane, leur preparation et leur application en therapeutique
FR9706945A FR2764288B1 (fr) 1997-06-05 1997-06-05 Derives de 5-naphtalen-1-yl-1,3-dioxane, leur preparation et leur application en therapeutique
FR9706946A FR2764289B1 (fr) 1997-06-05 1997-06-05 Derives de 5-naphtalen-1-yl-1,3-dioxane, leur preparation et leur application en therapeutique
PCT/FR1998/001113 WO1998055474A1 (fr) 1997-06-05 1998-06-03 Derives de 5-naphtalen-1-yl-1,3-dioxane, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
BR9810742A true BR9810742A (pt) 2000-09-12

Family

ID=27447000

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9810742-9A BR9810742A (pt) 1997-06-05 1998-06-03 Derivados de 5-naftalen -1il-1,3-dioxana, preparação dos mesmos e aplicação em terapia

Country Status (18)

Country Link
EP (1) EP0986552A1 (pt)
JP (1) JP2002502412A (pt)
KR (1) KR20010013435A (pt)
CN (1) CN1265658A (pt)
AR (1) AR012908A1 (pt)
AU (1) AU8025198A (pt)
BG (1) BG103937A (pt)
BR (1) BR9810742A (pt)
CA (1) CA2290695A1 (pt)
CO (1) CO4940480A1 (pt)
EE (1) EE9900560A (pt)
HU (1) HUP0002166A3 (pt)
IL (1) IL133242A0 (pt)
NO (1) NO995966L (pt)
PL (1) PL337234A1 (pt)
SK (1) SK166199A3 (pt)
TR (1) TR199903022T2 (pt)
WO (1) WO1998055474A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020107283A1 (en) * 2000-07-21 2002-08-08 Codd Ellen E. Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
FR2843964B1 (fr) * 2002-08-29 2004-10-01 Sanofi Synthelabo Derives de dioxane-2-alkylcarbamates, leur preparation et leur application en therapeutique

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0461958B1 (fr) * 1990-06-15 1994-09-14 Synthelabo Dérivés de 2-(aminoalkyl)-5-(arylalkyl)-1,3-dioxanes, leur préparation et leur application en thérapeutique
FR2714055B1 (fr) * 1993-12-22 1996-01-19 Synthelabo Dérivés de 5-(arylalkyl)-1,3-dioxane substitués en position 2, leur préparation et leur utilisation en thérapeutique.
FR2742152B1 (fr) * 1995-12-06 1998-01-16 Synthelabo Derives de 5-naphtalen-1-yl-1,3-dioxanes, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
SK166199A3 (en) 2000-06-12
CA2290695A1 (en) 1998-12-10
HUP0002166A2 (hu) 2001-06-28
TR199903022T2 (xx) 2000-04-21
EE9900560A (et) 2000-06-15
EP0986552A1 (fr) 2000-03-22
AU8025198A (en) 1998-12-21
HUP0002166A3 (en) 2002-12-28
NO995966D0 (no) 1999-12-03
BG103937A (en) 2000-07-31
CN1265658A (zh) 2000-09-06
IL133242A0 (en) 2001-03-19
NO995966L (no) 2000-02-04
KR20010013435A (ko) 2001-02-26
JP2002502412A (ja) 2002-01-22
WO1998055474A1 (fr) 1998-12-10
CO4940480A1 (es) 2000-07-24
PL337234A1 (en) 2000-08-14
AR012908A1 (es) 2000-11-22

Similar Documents

Publication Publication Date Title
NO20023457L (no) Nye piperidinforbindelser og legemidler inneholdende de samme
DK1077927T3 (da) Nye substituerede cykliske forbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
BR9807132A (pt) Derivados de pirrolidina tendo atividade inibitória de fosfolipase a2
PT1004578E (pt) Derivados hidroxamida do acido 5-oxo-pirrolidino-2-carboxilico
DK1265606T3 (da) Celleadhæsionsinhibitorer
ATE438624T1 (de) 2-pyridonderivate mit affinität für den cannabinoid-typ-2-rezeptor
BR9813848A (pt) Composto heterocìclico fundido substituìdo, uso do mesmo, e, composição farmacêutica.
DE69416848T2 (de) Amidino-derivate als no-synthetase inhibitoren
HUP0302962A2 (hu) Béta-karbolinszármazékok, ezeket a vegyületeket tartalmazó gyógyászati készítmények és a vegyületek alkalmazása
BR0210297A (pt) Derivados de n-arilfenilacetamida e composição farmacêutcia contendo os mesmos
BR0006823A (pt) Composição farmacêutica estabilizada, uso de composto de polipeptìdeo cìclico, preparação de injeção e pacote comercial
DK1140918T3 (da) Thrombininhibitorer
BR0113071A (pt) Compostos de 1,4-dihidropiridina como antagonistas da bradiquinina
BR0316609A (pt) Sinomenina e compostos de sinomenina, sìntese e uso
BR9810742A (pt) Derivados de 5-naftalen -1il-1,3-dioxana, preparação dos mesmos e aplicação em terapia
BR0002287A (pt) Compostos de piridina ou piperidina substituìdas, processo para preparação deles e composições farmacêuticas contendo-os
BR0106248A (pt) Inibidores de metaloprotease, processo para a sua preparação e composições farmacêuticas contendo os mesmos
DE69941307D1 (de) Prenyl transferasinhibitoren
BR9907426A (pt) Tetrahidronaftalenos
BR9714007A (pt) Novos derivados da eritromicina seu processo de preparação e sua aplicação como medicamentos
MY136928A (en) New isoquinoline compounds, a process for their preparation and pharmaceutical composition containing them
DK0682024T3 (da) Cyclohexan-derivater, fremgangsmåder til fremstilling og deres anvendelse som glucose-6-phosphatase inhibitorer
BR9811962A (pt) Métodos para baixar as contagens de plaquetas
ATE311877T1 (de) Lp(a)-mindernde mittel und inhibitoren der apoprotein (a) produktion
DK1312608T3 (da) Discodermolid-analoge samt deres farmaceutiske anvendelse

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A, 7A, 8A E 9A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1889 DE 20/03/2007.